Loading the records…
Loading the records…
HR5160 is an uncontroversial reauthorization bill for the C.W. Bill Young Cell Transplantation Program and cord blood inventory. It passed out of committee 48-0, indicating strong bipartisan support. The bill authorizes up to $33M annually for five years, but no actual money is appropriated. The commercial stem cell therapy sector is tiny and the bill primarily funds public cord blood banking and transplant registry operations, not private companies. No publicly traded companies are materially affected by this reauthorization.
No public companies are affected by this reauthorization. The funding goes entirely to non-profit organizations and public health agencies. Retail investors should not allocate capital based on this bill. The healthcare sector sees no measurable impact.
On May 21, 2026, the House Energy and Commerce Committee ordered HR5160 reported favorably by a 48-0 vote. This is the Stem Cell Therapeutic and Research Reauthorization Act of 2025, which extends the existing C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory through FY2031. It authorizes $31M for FY2026 and $33M for FY2027-2031 annually. However, authorization is not appropriation — actual funding requires separate annual appropriations bills. The program supports the national bone marrow donor registry (operated by the National Marrow Donor Program, a non-profit) and public cord blood banks. There are no direct grants, tax credits, or procurement programs that feed private sector revenue. The largest public cord blood bank, the National Cord Blood Inventory, is primarily a government-funded network. Publicly traded companies with cord blood banking services (e.g., StemCyte is private; Cryo-Cell International $CCEL is a small-cap private cord blood storage company, not a public equity) do not materially benefit from this reauthorization. The 19 cosponsors and unanimous committee vote signal near-certain passage, but the bill is purely a programmatic reauthorization with zero commercial market implications.
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive orders & memoranda affecting the same sectors or companies
This executive order requires all federal contractors and subcontractors to notify the White House and relevant agencies of any congressional requests related to their work with the executive branch, and to follow instructions to withhold information deemed protected by executive privilege. It directs agencies to enforce these requirements through contract termination or debarment, and tasks the Office of Management and Budget with developing implementation guidance. The order aims to protect executive branch confidentiality and enhance efficiency in federal contracting by preventing uncoordinated disclosures to Congress.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →